Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

The development of resilience among rheumatoid arthritis patients: a qualitative study.

Shaw Y, Bradley M, Zhang C, Dominique A, Michaud K, McDonald D, Simon TA.

Arthritis Care Res (Hoboken). 2019 Jul 8. doi: 10.1002/acr.24024. [Epub ahead of print]

PMID:
31282121
2.
3.

Risk of Biologics and Glucocorticoids in Patients With Rheumatoid Arthritis Undergoing Arthroplasty: A Cohort Study.

George MD, Baker JF, Winthrop K, Alemao E, Chen L, Connolly S, Hsu JY, Simon TA, Wu Q, Xie F, Yang S, Curtis JR.

Ann Intern Med. 2019 May 21. doi: 10.7326/M18-2217. [Epub ahead of print]

PMID:
31108503
4.

Comparative safety of abatacept in rheumatoid arthritis with COPD: A real-world population-based observational study.

Suissa S, Hudson M, Dell'Aniello S, Shen S, Simon TA, Ernst P.

Semin Arthritis Rheum. 2019 Mar 16. pii: S0049-0172(19)30023-X. doi: 10.1016/j.semarthrit.2019.03.007. [Epub ahead of print]

PMID:
30979397
5.

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study.

Montastruc F, Renoux C, Hudson M, Dell'Aniello S, Simon TA, Suissa S.

Semin Arthritis Rheum. 2019 Jun;48(6):1053-1058. doi: 10.1016/j.semarthrit.2019.01.009. Epub 2019 Jan 25.

PMID:
30772001
6.

Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes.

George MD, Baker JF, Winthrop K, Alemao E, Chen L, Connolly S, Hsu JY, Simon TA, Wu Q, Xie F, Yang S, Curtis JR.

Arthritis Care Res (Hoboken). 2019 Feb 11. doi: 10.1002/acr.23843. [Epub ahead of print]

PMID:
30740938
7.

Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study.

Montastruc F, Renoux C, Dell'Aniello S, Simon TA, Azoulay L, Hudson M, Suissa S.

Rheumatology (Oxford). 2019 Apr 1;58(4):683-691. doi: 10.1093/rheumatology/key352.

PMID:
30535094
8.

Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study.

Simon TA, Kawabata H, Ray N, Baheti A, Suissa S, Esdaile JM.

Adv Ther. 2017 Nov;34(11):2481-2490. doi: 10.1007/s12325-017-0627-3. Epub 2017 Oct 24.

9.

Erratum to: Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis.

Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S.

Arthritis Res Ther. 2016 May 4;18(1):100. No abstract available.

10.

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation.

Simon TA, Pan X, Kawabata H, Huang HY, Azoulay L.

Cardiovasc Ther. 2016 Apr;34(2):94-9. doi: 10.1111/1755-5922.12174.

11.

Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis.

Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S.

Arthritis Res Ther. 2015 Aug 15;17:212. doi: 10.1186/s13075-015-0728-9. Review. Erratum in: Arthritis Res Ther. 2016;18(1):100.

12.

Pregnancy outcomes following exposure to abatacept during pregnancy.

Kumar M, Ray L, Vemuri S, Simon TA.

Semin Arthritis Rheum. 2015 Dec;45(3):351-6. doi: 10.1016/j.semarthrit.2015.06.016. Epub 2015 Jun 26.

13.

Comparison of costs and discharge outcomes for patients hospitalized for ischemic or hemorrhagic stroke with or without atrial fibrillation in the United States.

Pan X, Simon TA, Hamilton M, Kuznik A.

J Thromb Thrombolysis. 2015 May;39(4):508-15. doi: 10.1007/s11239-014-1144-8.

14.

Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes.

Azoulay L, Dell'Aniello S, Simon TA, Renoux C, Suissa S.

Eur Heart J. 2014 Jul 21;35(28):1881-7. doi: 10.1093/eurheartj/eht499. Epub 2013 Dec 18.

PMID:
24353282
15.

Warfarin and Aspirin Use for Stroke Prevention Among Patients With Atrial Fibrillation: The US National Health and Wellness Survey.

Goren A, Liu X, Gupta S, Simon TA, Phatak H.

Am J Ther. 2015 Jul-Aug;22(4):248-56. doi: 10.1097/MJT.0000000000000001.

PMID:
24326696
16.

Quality of life, activity impairment, and healthcare resource utilization associated with atrial fibrillation in the US National Health and Wellness Survey.

Goren A, Liu X, Gupta S, Simon TA, Phatak H.

PLoS One. 2013 Aug 12;8(8):e71264. doi: 10.1371/journal.pone.0071264. eCollection 2013.

17.

The efficacy and safety of oral anticoagulants in warfarin-suitable patients with nonvalvular atrial fibrillation: systematic review and meta-analysis.

Mitchell SA, Simon TA, Raza S, Jakouloff D, Orme ME, Lockhart I, Drost P.

Clin Appl Thromb Hemost. 2013 Nov-Dec;19(6):619-31. doi: 10.1177/1076029613486539. Epub 2013 May 22. Review.

PMID:
23698729
18.

Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices.

Ewen E, Zhang Z, Simon TA, Kolm P, Liu X, Weintraub WS.

Vasc Health Risk Manag. 2012;8:587-98. doi: 10.2147/VHRM.S34280. Epub 2012 Oct 19.

19.

Perceived or actual barriers to warfarin use in atrial fibrillation based on electronic medical records.

Rosenman MB, Simon TA, Teal E, McGuire P, Nisi D, Jackson JD.

Am J Ther. 2012 Sep;19(5):330-7. doi: 10.1097/MJT.0b013e3182546840.

PMID:
22964558
20.

Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records.

Rosenman MB, Baker L, Jing Y, Makenbaeva D, Meissner B, Simon TA, Wiederkehr D, Deitelzweig S.

Curr Med Res Opin. 2012 Sep;28(9):1407-14. Epub 2012 Jul 26. Review.

PMID:
22746356
21.

A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study.

Azoulay L, Dell'Aniello S, Simon TA, Langleben D, Renoux C, Suissa S.

BMC Cardiovasc Disord. 2012 Jun 26;12:49. doi: 10.1186/1471-2261-12-49.

22.

The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis.

Cohen A, Drost P, Marchant N, Mitchell S, Orme M, Rublee D, Simon TA, Sutton A.

Clin Appl Thromb Hemost. 2012 Nov;18(6):611-27. doi: 10.1177/1076029612437579. Epub 2012 Mar 2. Review.

PMID:
22387582
23.

Enoxaparin dosing after discharge from US hospitals in patients with total knee replacement.

Wright R, Kawabata H, Pan X, Simon TA, Ramacciotti E.

Clin Appl Thromb Hemost. 2012 Sep;18(5):514-8. doi: 10.1177/1076029611433643. Epub 2012 Feb 16.

PMID:
22345487
24.

Anticoagulation prophylaxis in orthopedic surgery: an efficiency frontier approach.

Migliaccio-Walle K, Rublee D, Simon TA.

Postgrad Med. 2012 Jan;124(1):41-9. doi: 10.3810/pgm.2012.01.2516.

PMID:
22314113
25.

Characterization of a multi-axis ion chamber array.

Simon TA, Kozelka J, Simon WE, Kahler D, Li J, Liu C.

Med Phys. 2010 Nov;37(11):6101-11.

PMID:
21158322
26.

Wide field array calibration dependence on the stability of measured dose distributions.

Simon TA, Simon WE, Kahler D, Li J, Liu C.

Med Phys. 2010 Jul;37(7):3501-9.

PMID:
20831056
27.

Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment.

Simon TA, Askling J, Lacaille D, Franklin J, Wolfe F, Covucci A, Suissa S, Hochberg MC; Abatacept Epidemiology Study Group.

Arthritis Res Ther. 2010;12(2):R67. doi: 10.1186/ar2984. Epub 2010 Apr 14.

28.

An MLC calibration method using a detector array.

Simon TA, Kahler D, Simon WE, Fox C, Li J, Palta J, Liu C.

Med Phys. 2009 Oct;36(10):4495-503.

29.

Epidemiologic critique of literature on post-transplant neoplasms in solid organ transplantation.

Lanza LL, Wang L, Simon TA, Irish WD.

Clin Transplant. 2009 Sep-Oct;23(5):582-8. doi: 10.1111/j.1399-0012.2009.01061.x. Epub 2009 Aug 24.

PMID:
19708925
30.

On the sensitivity of patient-specific IMRT QA to MLC positioning errors.

Yan G, Liu C, Simon TA, Peng LC, Fox C, Li JG.

J Appl Clin Med Phys. 2009 Feb 5;10(1):2915.

31.

Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment.

Simon TA, Smitten AL, Franklin J, Askling J, Lacaille D, Wolfe F, Hochberg MC, Qi K, Suissa S.

Ann Rheum Dis. 2009 Dec;68(12):1819-26. doi: 10.1136/ard.2008.097527. Epub 2008 Dec 3.

32.

Rates of first infection following kidney transplant in the United States.

Snyder JJ, Israni AK, Peng Y, Zhang L, Simon TA, Kasiske BL.

Kidney Int. 2009 Feb;75(3):317-26. doi: 10.1038/ki.2008.580. Epub 2008 Nov 19.

33.

Multileaf collimator characteristics and reliability requirements for IMRT Elekta system.

Liu C, Simon TA, Fox C, Li J, Palta JR.

Int J Radiat Oncol Biol Phys. 2008;71(1 Suppl):S89-92. doi: 10.1016/j.ijrobp.2007.07.2392.

PMID:
18406946
34.

A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis.

Smitten AL, Simon TA, Hochberg MC, Suissa S.

Arthritis Res Ther. 2008;10(2):R45. doi: 10.1186/ar2404. Epub 2008 Apr 23.

35.

The risk of hospitalized infection in patients with rheumatoid arthritis.

Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA.

J Rheumatol. 2008 Mar;35(3):387-93. Epub 2008 Feb 1.

PMID:
18260176
36.

The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom.

Smitten AL, Choi HK, Hochberg MC, Suissa S, Simon TA, Testa MA, Chan KA.

Arthritis Rheum. 2007 Dec 15;57(8):1431-8.

37.

Tomographic physical phantom of the newborn child with real-time dosimetry I. Methods and techniques for construction.

Jones AK, Simon TA, Bolch WE, Holman MM, Hintenlang DE.

Med Phys. 2006 Sep;33(9):3274-82.

PMID:
17022222
38.

Evidence for genetic modifiers of postnatal lethality in PWS-IC deletion mice.

Chamberlain SJ, Johnstone KA, DuBose AJ, Simon TA, Bartolomei MS, Resnick JL, Brannan CI.

Hum Mol Genet. 2004 Dec 1;13(23):2971-7. Epub 2004 Sep 30.

PMID:
15459179
39.

The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy.

Havranek EP, Simon TA, L'Italien G, Smitten A, Hauber AB, Chen R, Lapuerta P.

J Card Fail. 2004 Aug;10(4):339-43.

PMID:
15309702
40.

The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy.

Rodby RA, Chiou CF, Borenstein J, Smitten A, Sengupta N, Palmer AJ, Roze S, Annemans L, Simon TA, Chen RS, Lewis EJ; Collaborative Study Group.

Clin Ther. 2003 Jul;25(7):2102-19.

PMID:
12946554
42.

A health perception score predicts cardiac events in patients with heart failure: results from the IMPRESS trial.

Havranek EP, Lapuerta P, Simon TA, L'Italien G, Block AJ, Rouleau JL.

J Card Fail. 2001 Jun;7(2):153-7.

PMID:
11420767
43.

Assigning time-linked exposure status to controls in unmatched case-control studies: alcohol use and nearly lethal suicide attempts.

Kresnow M, Powell KE, Webb KB, Mercy JA, Potter LB, Simon TA, Ikeda RM, Frankowski R.

Stat Med. 2001 May 15-30;20(9-10):1479-85.

PMID:
11343368
44.

Tuberculosis in hemodialysis patients in New Jersey: a statewide study.

Simon TA, Paul S, Wartenberg D, Tokars JI.

Infect Control Hosp Epidemiol. 1999 Sep;20(9):607-9.

PMID:
10501258
45.

Safety of irbesartan in the treatment of mild to moderate systemic hypertension.

Simon TA, Gelarden RT, Freitag SA, Kassler-Taub KB, Davies R.

Am J Cardiol. 1998 Jul 15;82(2):179-82.

PMID:
9678288
46.

Selective embolisation of intrahepatic aneurysms.

Reid C, Cameron D, Simon TA, Ives J, Hall JC.

Aust N Z J Surg. 1992 Jul;62(7):582-4.

PMID:
1610327

Supplemental Content

Loading ...
Support Center